Decreased commitment to production/sales/new generics
By Lee, Jeong-Hwan | translator Kim, Jung-Ju
23.04.10 05:50:56
°¡³ª´Ù¶ó
0
Ministry of Health and Welfare, full-fledged public-private consultative body for first in class and generics
Prospects for policy announcements in the first half of the year
"(To the government), it seems that the price adjustment of generic drugs is always recognized as the easiest and easiest way. For pharmaceutical companies that are constantly striving to create new drugs, generics are the driving force. Only pharmaceutical companies that do not directly produce drugs or do research and development Please consider the hard way to regulate tweezers." Domestic pharmaceutical companies are becoming more concerned as the Min
Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)